How Do Women Get Trichomoniasis: Spread and Risk Factors

Women get trichomoniasis primarily through penile-vaginal sexual contact with an infected partner, though the parasite can also spread through other forms of genital contact including digital (hand-to-genital) activity. The infection is caused by a single-celled parasite called Trichomonas vaginalis, and what makes it particularly easy to catch is that most infected men have no symptoms at all, meaning they unknowingly pass it along. While sex is by far the dominant route, the story of who gets trichomoniasis and why is shaped by a surprising mix of biological, behavioral, and social factors that go well beyond the act of transmission itself.

The Primary Route of Spread

Penile-vaginal intercourse is the main way women acquire trichomoniasis. The parasite has a strong affinity for vaginal mucosal tissue, which is why the vagina is its preferred environment in women. Partner studies dating back decades have consistently confirmed sexual contact as the dominant transmission method. But the picture is not limited to intercourse alone. Because the parasite thrives on vaginal tissue, any sexual activity that brings an infected person’s genital fluids or tissue into contact with the vagina can potentially transmit it. That includes digital sexual activity involving the vagina, such as mutual masturbation between women.¹

Non-sexual transmission is uncommon but has been documented. One study in Zambia among adolescent girls aged 13 to 16 found that among 397 self-reported virgins, roughly a quarter tested positive for trichomoniasis, suggesting that shared bathing water, damp towels, or other fomite contact could play a small role in some settings.¹ That said, these findings come from specific environments and do not represent how the vast majority of infections occur. For practical purposes, trichomoniasis is a sexually transmitted infection.

Asymptomatic Male Partners Are the Hidden Driver

One of the most important things to understand about how women get trichomoniasis is the role of men who carry the parasite without knowing it. The infection in men is often silent. A study examining semen samples from over 1,100 men detected the parasite in about 4.4% of asymptomatic males, and treatment of those men led to measurable improvements in semen quality, confirming active infection that had gone entirely unnoticed.² Because men rarely develop symptoms, they are unlikely to seek testing or treatment on their own.

Up to 70% of male sexual partners of women diagnosed with trichomoniasis can be infected themselves.³ This creates a cycle: a woman gets treated, but her untreated partner reinfects her the next time they have sex. The asymmetry in symptoms between men and women is a central reason the infection persists at such high rates globally.

How Condom Use and Partner Patterns Affect Risk

Behavioral patterns play a major role in who gets trichomoniasis and how often. A study of women diagnosed with the infection found that regular condom use was strikingly low at about 16%, and even lower with regular partners, at just 9%.⁴ That same study found that most diagnosed women actually had only one partner in the preceding three months, which undercuts the common assumption that trichomoniasis is mainly a disease of people with many sexual partners.

What turned out to matter more was what their male partners were doing. Men reported concurrency (having overlapping sexual partnerships) at significantly higher rates than the women they were matched with, about 47% versus 23%. And men who had concurrent partners were no more likely to use condoms with their regular partners.⁴ So a woman with a single partner can still be at high risk if that partner has unprotected sex with others. This is a common blind spot in how people assess their own risk.

The Vaginal Microbiome and Susceptibility

Not every sexual exposure to the parasite leads to infection. A woman’s vaginal environment plays a real role in whether the parasite gains a foothold. Bacterial vaginosis, a condition where the normal balance of vaginal bacteria is disrupted, has been consistently linked to a higher chance of acquiring trichomoniasis. A systematic review and meta-analysis found that women with bacterial vaginosis had roughly double the odds of developing a new trichomoniasis infection compared to women without it.⁵

Even women who don’t meet the full threshold for bacterial vaginosis but have an intermediate disruption in their vaginal bacteria face elevated risk. One large study found that women with moderately disrupted vaginal flora had about 1.7 times the risk of acquiring trichomoniasis, while those with full-blown bacterial vaginosis had roughly 2.4 times the risk.⁶ Research has also begun identifying specific bacterial species in the vagina that may raise or lower susceptibility, though that work is still in early stages.⁷ The practical takeaway is that vaginal health is not just a matter of comfort; it directly affects vulnerability to sexually transmitted infections.

Why Douching Raises Risk

Vaginal douching has been linked to higher rates of trichomoniasis across multiple studies. In a study of pregnant women in Cameroon, the practice of douching was significantly associated with trichomoniasis infection.⁸ Research on adolescent and young adult women at high risk for sexually transmitted infections found that douching done after sex or in response to symptoms was associated with positive infection tests, while douching related to menstruation was not.⁹

The likely mechanism is the same one behind the microbiome connection. Douching disrupts the vaginal bacterial community, washing away protective lactobacilli and raising the pH, which creates conditions more favorable for the parasite. This is one of the clearest and most actionable risk factors: stopping the practice of douching can reduce susceptibility to trichomoniasis and other vaginal infections alike.

Age Patterns That Defy Expectations

Many sexually transmitted infections peak in young adults and decline steadily with age. Trichomoniasis doesn’t follow that pattern. A large commercial laboratory study of U.S. testing data found a bimodal distribution: a first peak at ages 21 to 22 with detection rates around 4%, and a higher second peak at ages 48 to 51 with rates of about 5.4 to 5.8%.¹⁰ This is the opposite of what’s seen with chlamydia, which peaks in teenagers and drops sharply after the early twenties.

The second peak near menopause likely reflects several converging factors. Declining estrogen levels thin the vaginal lining and shift the vaginal environment in ways that may favor the parasite. A Chinese study found that menopausal women were more likely to be infected with trichomoniasis than premenopausal women, even after accounting for other risk factors.¹¹ Older women are also screened less frequently for sexually transmitted infections, and providers may be less likely to consider trichomoniasis in a middle-aged patient presenting with vaginal symptoms, allowing infections to persist undetected.

Poverty, Education, and Structural Risk

Trichomoniasis in the United States is not distributed evenly across income and education levels. National data from a large representative sample found that people living below the poverty level had a prevalence of about 3.9%, compared to 0.6% among those at or above it. Not finishing high school was also independently associated with higher prevalence.¹²

These disparities are not simply about individual behavior. Research on neighborhood-level effects found that living in areas with higher concentrations of poverty was significantly associated with trichomoniasis among young adults, with an adjusted odds ratio of 1.25. Racial disparities that appeared in initial analyses were largely explained by neighborhood poverty, meaning the structural environment mattered more than race itself as a driver of infection.¹³ A systematic review of sexually transmitted infections in Black women similarly concluded that lower income and lower educational attainment were the primary social determinants of health associated with increased risk.¹⁴

What this means practically is that access to healthcare, routine screening, and partner treatment all track with socioeconomic status. A woman who cannot easily see a provider, whose partner lacks healthcare access, or who lives in an area without affordable sexual health services faces a compounded risk that has little to do with her personal choices.

Transmission Between Women

Although penile-vaginal contact is the most common route, trichomoniasis can also spread between female sexual partners. Because the parasite infects vaginal mucosal tissue, digital contact, shared sex toys, or any activity that transfers vaginal secretions from one woman to another can transmit the infection.¹ The risk is lower than in heterosexual intercourse, but it is real, and women who have sex exclusively with women should not assume they are immune to the infection. Using barriers during digital or toy-sharing activity and washing shared items between uses can reduce risk.

The Reinfection Problem

Getting treated once does not mean you are done with trichomoniasis. Reinfection rates are high enough that clinical guidelines recommend retesting all treated women at three months.³ Reinfection usually happens because male partners were not treated at the same time. Even in studies where partner treatment was attempted, reinfection rates for trichomoniasis were around 15%, higher than for other sexually transmitted infections treated in the same study.¹⁵

This is partly because the body does not develop lasting immunity to the parasite. Infection does trigger an immune response, including antibodies in both the blood and vaginal secretions, but that response can lead to clearance, persistence, or tissue damage depending on individual variation. It does not prevent reinfection.¹⁶ A woman can be reinfected immediately after completing treatment if her partner remains untreated.

Why So Many Cases Go Undiagnosed

The tendency for trichomoniasis to remain asymptomatic contributes enormously to its spread.¹⁷ Many women with active infections have no itching, discharge, or discomfort. Among those who do get tested, the method used matters a great deal. The traditional approach of examining a wet-mount slide under a microscope caught only about 38% of confirmed infections in one head-to-head comparison. More modern tests, including PCR-based methods and rapid antigen tests, detected 88 to 92% of cases.¹⁸

In many clinics, especially in resource-limited settings, microscopy is still the go-to method. That means a woman can walk in with symptoms, get tested, receive a negative result, and walk out with an active infection that continues to spread to partners. If you have been tested for trichomoniasis using only a microscope slide and told you are negative, the result may not be reliable. Nucleic acid amplification tests are far more accurate, and asking specifically what type of test is being used is a reasonable step.

Connections to HIV

Trichomoniasis is not just an inconvenience. It has real consequences for susceptibility to other infections, particularly HIV. Several biological mechanisms explain the link. The parasite damages the vaginal lining, weakening the physical barrier that normally helps keep HIV out. It also triggers inflammation that draws HIV target cells to the area, and its association with bacterial vaginosis creates yet another pathway to increased HIV vulnerability.¹⁹ This cascade of effects has led public health experts to recognize trichomoniasis not as the harmless nuisance it was once considered, but as a significant facilitator of HIV transmission.²⁰

Risks During Pregnancy and Delivery

Pregnant women with trichomoniasis face elevated risks that extend to the baby. A systematic review and meta-analysis found significant associations between trichomoniasis and preterm delivery, pre-labor rupture of membranes (about 1.9 times the odds), and low birth weight (about twice the odds).²¹ Earlier work had identified similar associations at mid-pregnancy.²²

The parasite can also be transmitted from mother to baby during vaginal delivery. A study of HIV-infected pregnant women in South Africa found that mother-to-child transmission occurred in about 24% of cases where the mother had trichomoniasis.²³ In newborns, this can result in either transient colonization that resolves on its own or, less commonly, an active infection that requires treatment.²⁴ Given these stakes, screening for trichomoniasis in pregnancy, particularly in women with risk factors, is genuinely important.

Drug-Resistant Infections

The standard treatment for trichomoniasis is metronidazole, a widely available antibiotic that works well in most cases. But at least 5% of clinical trichomoniasis cases involve parasites that are resistant to the drug.²⁵ For women who keep testing positive despite taking their medication correctly and ensuring their partners are also treated, drug resistance is worth considering as an explanation. Higher doses, longer courses, or alternative drugs may be needed, and these cases often benefit from consultation with an infectious disease specialist. Drug resistance is not common enough to be the first thing to worry about, but it is common enough that a woman who has been treated multiple times without clearing the infection should raise the possibility with her provider rather than assuming she keeps getting reinfected.

1
PubMed Central. Trichomoniasis
2
Springer Link. Semen characteristics of asymptomatic males affected by Trichomonas vaginalis
3
PubMed Central. Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity
4
PubMed Central. Partnership concurrency status and condom use among women diagnosed with Trichomonas vaginalis
5
PubMed Central. Bacterial Vaginosis and Its Association With Incident Trichomonas vaginalis Infections: A Systematic Review and Meta-Analysis
6
PubMed Central. Bacterial vaginosis and the risk of Trichomonas vaginalis acquisition among HIV-1 negative women
7
PubMed Central. Specific Vaginal Bacteria Are Associated With an Increased Risk of Trichomonas vaginalis Acquisition in Women
8
Open Journal of Obstetrics and Gynecology. Prevalence and Factors Associated with Trichomoniasis, Bacterial Vaginosis, and Candidiasis among Pregnant Women in a Regional Hospital in Cameroon
9
PubMed. Douching behaviors reported by adolescent and young adult women at high risk for sexually transmitted infections
10
PubMed. Trichomonas vaginalis detection rates in comparison with Chlamydia trachomatis by age and state in a commercial laboratory setting
11
Scientific Reports. Development and validation of a predictive model for the risk of developing trichomonas vaginitis in women
12
Clinical Infectious Diseases. Prevalence and Correlates of Trichomonas vaginalis Infection Among Men and Women in the United States
13
PubMed Central. Neighborhood Social Disorganization and the Acquisition of Trichomoniasis Among Young Adults in the United States
14
PubMed. A Systematic Review Exploring Racial Disparities, Social Determinants of Health, and Sexually Transmitted Infections in Black Women
15
PubMed Central. Patient-Delivered Partner Treatment for Chlamydia, Gonorrhea, and Trichomonas Infection Among Pregnant and Postpartum Women in Kenya
16
PubMed. Humoral and T cell-mediated immune response against trichomoniasis
17
Physica Scripta. Unraveling the dynamics of trichomoniasis transmission: modeling reinfection and asymptomatic spread with optimal control strategies based on United States demographics
18
International Journal of STD and AIDS. Microscopy outperformed in a comparison of five methods for detecting Trichomonas vaginalis in symptomatic women
19
PubMed Central. Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis
20
PubMed Central. Epidemiology and treatment of trichomoniasis
21
PubMed Central. Trichomoniasis and adverse birth outcomes: a systematic review and meta-analysis
22
PubMed. Trichomonas vaginalis associated with low birth weight and preterm delivery
23
PubMed. Mother-to-child transmission of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in HIV-infected pregnant women in South Africa
24
PubMed. Trichomonas vaginalis in neonates
25
PubMed Central. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis